Urgent need

RNA therapeutics are accelerating faster than current manufacturing technologies can support.

Untapped potential

Nature encodes >200 RNA modifications – chemical synthesis only accesses ~20.

EnPlusOne solution

A flexible enzymatic platform that unlocks scale and access to new RNA therapeutics.

Scale

Unrestricted synthesis and manufacturing capacity for RNA therapeutics

Length

Higher cycle efficiencies for high purity long RNA

Modifications

Access to a broader RNA design space with novel modifications